Skip to main content
Top

15-11-2016 | Acute leukemia | Article

Clinical manifestations and diagnosis

Author: Klaus Metzeler

Presenting symptoms in patients with acute leukemia are highly variable (Table 3.1) but most are caused by hematopoietic insufficiency. Typically, the onset of symptoms is acute, within weeks to a few months before diagnosis, except in those patients who develop leukemia secondary to a pre-existing hematologic disease such as myelodysplastic syndromes (MDS) or myeloproliferative neoplasms. Infiltration of extramedullary organs by leukemic blasts is found in 2.5–9% of acute myeloid leukemia (AML) patients. Lymphadenopathy and/or hepatosplenomegaly are present in up to 50% of patients with acute lymphoblastic leukemia (ALL), and patients with T-lineage ALL frequently present with a mediastinal mass. Involvement of the central nervous system (CNS), most commonly manifesting in the cerebrospinal fluid (CSF), is detectable in <5% of adults with AML and in ~5% of adults with ALL at the time of initial diagnosis [1]. Fever is one of the most common presenting symptoms in patients with acute leukemias. Fever should always be interpreted as a sign of infection, and should prompt a careful search for infectious foci. Rapid initiation of empirical, broad-spectrum antibiotic coverage is usually indicated in febrile patients. Fever as a direct manifestation of leukemia without coexisting infection is rare.

Literature
  1. Loeb KR, Cherian S, Becker PS, et al. Comparative analysis of flow cytometry and morphology for the detection of acute myeloid leukaemia cells in cerebrospinal fluid. Br J Haematol. 2016;172:134-136.
  2. Roug AS, Hansen MC, Nederby L, Hokland P. Diagnosing and following adult patients with acute myeloid leukaemia in the genomic age. Br J Haematol. 2014;167:162-176.
  3. Haferlach T. How does one work-up an acute myeloid leukemia patient in the molecular era? http://​learningcenter.​ehaweb.​org/​eha/​2015/​20th/​103570/​torsten.​haferlach.​how.​does.​one. work.up.an.aml.patient.in.the.molecular.era.html?f=m6t1576. Accessed August 12, 2016.
  4. Dohner H, Estey EH, Amadori S, et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 2010;115:453-474.
  5. Bene MC, Nebe T, Bettelheim P, et al. Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10. Leukemia. 2011;25:567-574.
  6. Kayser S, Dohner K, Krauter J, et al. The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML. Blood. 2011;117:2137-2145.
  7. Mauritzson N, Albin M, Rylander L, et al. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001. Leukemia. 2002;16:2366-2378.
  8. Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391-2405.
  9. Walter RB, Othus M, Burnett AK, et al. Significance of FAB subclassification of “acute myeloid leukemia, NOS” in the 2008 WHO classification: analysis of 5848 newly diagnosed patients. Blood. 2013;121:2424-2431.
  10. Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114:937-951.
  11. Bakst RL, Tallman MS, Douer D, Yahalom J. How I treat extramedullary acute myeloid leukemia. Blood. 2011;118:3785-3793.
  12. Dohner H, Weisdorf DJ, Bloomfield CD. Acute Myeloid Leukemia. N Engl J Med. 2015;373:1136-1152.
  13. McGregor S, McNeer J, Gurbuxani S. Beyond the 2008 World Health Organization classification: the role of the hematopathology laboratory in the diagnosis and management of acute lymphoblastic leukemia. Semin Diagn Pathol. 2012;29:2-11.